Zevra Therapeutics Inc.

NASDAQ: ZVRA · Real-Time Price · USD
9.51
0.23 (2.48%)
At close: Aug 21, 2025, 3:59 PM
9.62
1.16%
After-hours: Aug 21, 2025, 07:59 PM EDT

Zevra Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-105.51M -46.05M -41.54M -8.55M
Depreciation & Amortization
6.39M 1.01M 944K 257K
Stock-Based Compensation
14.91M 5.95M 4.29M 2.44M
Other Working Capital
-1.04M 3.63M 3.09M -295K
Other Non-Cash Items
5.82M -329K 17.99M 460K
Deferred Income Tax
15.37M n/a n/a 16.2M
Change in Working Capital
-6.64M 5.88M -406K -357K
Operating Cash Flow
-69.67M -33.53M -18.72M 10.44M
Capital Expenditures
n/a -296K -93K -102K
Cash Acquisitions
n/a -30.4M -14.09M n/a
Purchase of Investments
-41.16M -45.81M -22.54M -15.42M
Sales Maturities Of Investments
25M 59.12M 36.63M n/a
Other Investing Acitivies
-6M n/a -36.63M n/a
Investing Cash Flow
-22.16M -17.39M -36.72M -15.52M
Debt Repayment
16.29M 25.59M 12.78M -38.1M
Common Stock Repurchased
n/a -3.45M -4.72M -2.81M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.3M 6.32M 291K 104.73M
Financial Cash Flow
82.11M 28.46M 8.35M 113.11M
Net Cash Flow
-9.26M -22.42M -46.88M 108.02M
Free Cash Flow
-69.67M -33.83M -18.81M 10.34M